Developing Controlled Metabolic Accelerators (CMAs) as a New Class of Investigational Medicines to Combat Obesity & Chronic Metabolic Diseases
Time: 11:00 am
day: Pre-Conference Day
Details:
- Developing Controlled Metabolic Accelerators (CMAs) has the advantage of increasing metabolic rate without elevating heart rate, providing the benefit of a more tolerable and sustainable treatment for patients
- Targeting metabolic pathways directly allows for the preferential use of fat for fuel, resulting in the benefit of significant and selective fat reduction
- This novel mechanism of action allows for the treatment of both obesity and chronic metabolic diseases simultaneously, which provides the benefit of a holistic and comprehensive improvement in overall patient health
Speakers:
